The human pathogen
A comprehensive library of
The combination of a genetic screening and a modelling approach revealed that a series of transporters help
In a pilot study on virulent strains or mutants of
To obtain an overview of genes required by
For the identification of insertional mutations that affect the ability of
Genes identified to be required for intracellular replication of
| fold reduction | fold reduction | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||
| gene name or number | protein name, or protein homology/similarity to | polar effect | invasion/adhesion | gene name or number | protein name, or protein homology/similarity to | polar effect | invasion/adhesion | ||
|
|
|
||||||||
| 1lmo0441 | penicillin-binding protein (D-alanyl-D-alanine carboxypeptidase) | no | 9.4 | 6.1 | 5lmo0618 | protein kinase | no | 11.0 | 2.0 |
| 2,8lmo1085 | teichoic acid biosynthesis protein B | rf | 12.3 | 2 | 1lmo0763 | hypothetical Ser/Thr protein phosphatase family protein | possible | 5.5 | 2.0/5.0 |
| lmo1088 | teichoic acid biosynthesis protein B | rf | 26.2 | 1.9 |
|
||||
| 7lmo1713 | actin-like ATPase involved in cell morphogenesis | no | 3.6 | 3.5 | lmo0594 | homoserine O-acetyltransferase | no | 7.7 | 3.9 |
| 3,5,7 |
penicillin-binding protein 2B | rf | 3.8 | 2.6 | 6,8lmo1235 | aspartokinase II a subunit | no | 5.9 | nd |
| 1lmo2555 | Glycosyltransferase | rf | 8.1 | 3.9/5.0 | lmo1495 | 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase | possible | 6.2 | 1.0 |
|
|
lmo1916 | peptidase | no | 7.0 | 2.4 | ||||
| 4lmo0135 ( |
oligopeptide ABC transport system, substrate binding protein | rf | 13.6 | 2.2 | 8 |
3-dehydroquinate synthase | rf | 2.8 | 1.4 |
| 4lmo0136 | oligopeptide ABC transport system, substrate binding protein | rf | 5.0 | 2.4 | 4,6 |
acetolactate synthase (acetohydroxy-acid synthase) | rf | 5.5 | 1.8 |
| lmo0137 | oligopeptide ABC transport system, permease | no | 9.7 | 1.9 | 4,6 |
ketol-acid reductoisomerase | no | 3.2 | 3 |
| 4lmo0195 | ABC-type antimicrobial peptide transport system, permease | no | 6.3 | nd | lmo2051 | weakly similar to proteases | no | 4.1 | 1 |
| lmo0495 | permease of the drug/metabolite transporter (DMT) superfamily | possible | 4.2 | 2.3 | lmo2694 | lysine decarboxylase | possible | 5.5 | 0 |
| 4lmo0584 | conserved hypothetical membrane protein, putative permease | no | 7.2 | 3.0 | lmo2770 | γ-glutamylcysteine synthetase and cyanophycin synthetase | no | 5.8 | 2.3 |
| lmo0645 | amino acid transporter | no | 4.9 | 1.5 | 6 |
phosphoserine aminotransferase | possible | 5.7 | 3.5 |
| 5lmo0650 | conserved membrane protein | possible | 2.8 | 2.0 |
|
||||
| lmo0787 | amino acid transporter | no | 3.4 | 1.0 | 1,5 |
adenylosuccinate synthetase | no | 14.9 | /4.0 |
| lmo0810 | spermidine/putrescine-binding protein | no | 7.4 | 3.1 | phosphoribosylformylglycinamidine synthetase | rf | 12.0 | nd | |
| 3lmo1003 | phosphotransferase system enzyme I | no | 3.4 | 1.0 | 8 |
phosphoribosylformylglycinamidine synthetase | rf | 11.0 | 1.0 |
| glycine betaine ABC transporter, ATP-binding protein | rf | 10.0 | 4.0 | orotatephosphoribosyltransferase | no | 5.5 | 2.5 | ||
| 8lmo1416 | hypothetical transporter | no | 5.3 | 1.0 |
|
||||
| 6 |
glycine betaine/carnitine/choline ABC transporter, ATP-binding protein | rf | 15.7 | 1.7 | 5,8 |
CDP-ME synthase involved in isoprenoid biosynthesis | no | 4.7 | 2.3 |
| 5lmo1431 | ABC transporter, ATP binding protein | no | 4.8 | 3 | lmo1005 | 3-hydroxyisobutyrate dehydrogenase | no | 11.0 | 1.8 |
| lmo1506 | ABC-type antimicrobial peptide transport system, permease | rf | 6.2 | 2.3 | lmo1363 | geranyltransferase | no | 5.0 | 2.8 |
| lmo1739 | amino acid ABC transporter | rf | 5.5 | 2 | lmo2450 | carboxylesterase | possible | 4.2 | 3.0 |
| 3,5,7,8lmo1847 | ABC transporter specific for metal cations | no | 5.8 | 2.3 |
|
||||
| lmo2124 | maltodextrin ABC transport system, permease | rf | 3.4 | 0 | 5lmo0221 | hypothetical type III pantothenate kinase | possible | 6.9 | 1.0 |
| 1,3 |
oligopeptide ABC-transporter, ATP-binding protein | no | 21.0 | 8.0/4.0 | 1,3 |
pyridoxine kinase | no | 13.1 | 1/4.0 |
| lmo2227 | ABC transporter, ATP-binding protein | possible | 5.8 | 1.3 | lmo1043 | molybdopterin-guanine dinucleotide biosynthesis MobB | rf | 7.9 | 1.4 |
| lmo2249 | low-affinity inorganic phosphate transporter | no | 2.8 | 2.0 | lmo1932 | heptaprenyl diphosphate synthase component I | rf | 12.1 | 4.8 |
| lmo2353 | hypothetical Na+/H+ antiporter | no | 4.3 | 2.3 | L-aspartate oxidase | rf | 3.4 | 0 | |
| lmo2380 | protein involved in resistance to cholate/Na+ and in pH homeostasis | rf | 5.7 | 2.5 | 3lmo2102 | glutamine amidotransferase subunit PdxT (pyridoxine biosynthesis) | no | 4.0 | 3.3 |
| lmo2430 | rf | 75.6 | 5.0 | lmo2566 | biotin/lipoate A/B protein ligase family | possible | 6.2 | 2.0 | |
| lmo2816 | transport protein | no | 6.3 | 2.0 |
|
||||
| lmo2850 | sugar transport protein | rf | 16.5 | 0 | 5 |
DNA gyrase subunit B | rf | 9.6 | nd |
|
|
lmo0157 | ATP-dependent helicase | possible | 2.1 | 1.0 | ||||
| lmo0799 | oxygen/light sensor with PAS domain | no | 8.3 | 2.0 | transcription-repair coupling factor | possible | 8.9 | 3.7 | |
| lmo1508 | two-component sensor histidine kinase | no | 5.2 | 2.9 | lmo0588 | DNA photolyase | no | 9.6 | 2.0 |
|
|
formamidopyrimidine-DNA glycosylase | no | 5.2 | 1.1 | |||||
| lmo0091 | ATP synthase g chain, H+-transporting two-sector ATPase | rf | 5.7 | 2.0 | lmo1751 | hypothetical RNA methyltransferase | no | 6.2 | 2.0 |
| pyruvate-flavodoxin oxidoreductase | no | 6.4 | 3.6 | 8 |
asparaginyl-tRNA synthetases | no | 4.1 | 1.6 | |
| 5 |
H+-transporting ATP synthase chain α | rf | 7.7 | 2.7 | lmo2050 | exconuclease ABC (subunit A) | no | 5.1 | 2.0 |
| H+-transporting ATP synthase chain β | rf | 4.4 | 5.9 |
|
|||||
|
|
6 |
RecN | no | 14.8 | 1.9 | ||||
| lmo0680 | flagella-associated protein FlhA | rf | 7.0 | 3.1 | Holliday junction DNA helicase RuvB | possible | 9.4 | 3.9 | |
| 6lmo0700 | flagellar motor switch protein FliY | rf | 5.8 | 1.7 | 8 |
similar to ATP-dependent DNA helicase | no | 7.0 | 2.3 |
|
|
|
||||||||
| 1,2,6 |
putative peptidoglycan bound protein with LPXTG motif | no | 6.4 | 4.5 | 3 |
2-component response regulator protein | no | 3.4 | 1.0 |
| 8lmo0327 | protein with LPXTG motif, putative murein hydrolase activity | no | 6.9 | 3.0 | 6lmo0294 | transcription regulator, LysR- |
no | 7.4 | 3.1 |
| 4lmo0514 | internalin-like protein with LPXTG motif | no | 6.4 | 1.4 | lmo0535 | transcription regulator, LacI family | no | 9.5 | 1.0 |
| 4lmo0576 | hypothetical cell wall associated protein | no | 4.2 | 1.5 | 3 |
transcriptional regulator, Fur family | no | 5.5 | 1.0 |
| 2,8lmo1666 | peptidoglycan linked protein with LPXTG motif | no | 6.8 | 1.8 | lmo1994 | transcription regulators, LacI family | no | 9.0 | 1.4 |
| lmo2026 | hypothetical peptidoglycan bound protein with LPXTG motif | no | 8.7 | 1.4 |
|
||||
| 5lmo2504 | cell wall binding protein, peptidase-related enzyme | no | 4.8 | 2.0 | lmo0241 | hypothetical RNA methyltransferase, |
rf | 4.1 | 1.0 |
| 1 |
autolysin, N-acetylmuramoyl-L-alanine amidase | no | 3.8 | 5.3 | 1,3,5lmo1434 | RNA-metabolising metallo-β-lactamase | no | 9.6 | 3/22 |
|
|
|
||||||||
| transmembrane protein with phosphoesterase domain | possible | 4.1 | 2.0 | lmo0066 | toxin component of A/B toxin | rf | 2.8 | 1.0 | |
| 8lmo0182 | α-xylosidase and α-glucosidase | rf | 7.9 | 1.3 | 4lmo0585 | secreted protein | no | 4.8 | 1.0 |
| lmo0261 | phospho-β-glucosidase | no | 3.4 | 0 | lmo0587 | secreted protein, YapH from |
no | 3.4 | 1.0 |
| 8lmo0271 | phospho-β-glucosidase | possible | 4.1 | 1.0 |
|
||||
| lmo0517 | phosphoglycerate mutase | no | 13.8 | 2.3 | lmo0276 | hypothetical hydrolase, HAD superfamily | possible | 5.2 | 1.3 |
| 2lmo1031 | hypothetical L-fucose isomerase | rf | 11.1 | 2.1 | 2lmo0313 | hypothetical hydrolase, PHP superfamily | no | 2.8 | 1.0 |
| 2lmo1032 | Transketolase | rf | 14.4 | 4lmo0590 | hypothetical DAK2/DegV domain-containing protein | possible | 9.6 | 1.0 | |
| lmo1166 | NADPH-dependent butanol dehydrogenaseI | possible | 4.2 | 1.0 | lmo0765 | unknown protein | possible | 10.4 | 3.0 |
| 4 |
glycerol-3-phosphate dehydrogenase | no | 4.8 | 1.0 | 4,6,7lmo0794 | no | 12.4 | 2.0 | |
| 6lmo1244 | weakly similar to phosphoglycerate mutase 1 | no | 8.3 | 2.0 | lmo1379 | no | 4.8 | 3.0 | |
| lmo2005 | Oxidoreductase | no | 7.4 | 3.9 | 3lmo1402 | no | 2.1 | 2.0 | |
| lmo2015 | α-mannosidase | no | 6.4 | 1.7 | lmo1575 | phosphoesterase, DHH superfamily | no | n.d. | 1.0 |
| lmo2134 | fructose-1,6-biphosphate aldolase type II | no | 5.2 | 2.4 | 6,8lmo1700 | unknown protein | no | 4.6 | 1.3 |
| lmo2172 | propionate CoA-transferase | possible | 5.3 | 1.3 | 4lmo1830 | short chain dehydrogenase | no | 11.7 | 2.0 |
| lmo2247 | Oxidoreductase | possible | 5.0 | 2.4 | lmo1866 | hypothetical phosphotransferase | possible | 7.1 | 2.2 |
| 8lmo2446 | Glycosidase | no | 9.9 | 2.5 | lmo1920 | unknown protein | 16.5 | 1.0 | |
| lmo2586 | formate dehydrogenase α-chain | possible | 2.4 | 2.2 | lmo2516 | conserved hypothetical protein | possible | 3.6 | 1.2 |
| 6lmo2660 | Transketolase | rf | 3.0 | 2.6 | lmo2639 | unknown protein, contains DUF1312 domain | possible | 5.5 | 1.0 |
| lmo2764 | xylose operon regulatory protein and to glucose kinase | rf | 3.6 | 2.1 |
|
||||
| 2lmo2781 | β-glucosidase | rf | 6.5 | 2.0 | lmo0729 | no similarity | no | 4.8 | 1.0 |
| lmo2831 | Phosphoglucomutase | no | 5.3 | 2.8 | 2lmo1188 | no similarity | no | 5.1 | 3.5 |
| lmo1219 | no similarity | no | 4.8 | 2.0 | |||||
| lmo2129 | no similarity | no | 5.8 | 1.6 | |||||
1adhesion (seven genes) or invasion (four genes) defective as determined 35 min or 2 h post infection, respectively; 2genes without homologue in
Although IDM has the potential for termination-induced reduction of downstream gene expression [
All genes were classified into functional categories (Figure
Eight genes identified in the screening described here have no homologue in the apathogenic species
To discriminate between factors playing a role during intracellular multiplication from those that contribute to Caco-2 cell adhesion or invasion, the number of viable surface-attached or intracellular
The main anabolic and catabolic pathways of
Flux balance analysis [
The metabolic model allows to identify all cellular pathways affected by each knockout mutation. Applying PERL scripts, we identified the number of mutants impairing the same pathway. Finally, all pathways relevant to intracellular survival were ranked with the highest redundancy at the top, and the key enzymes involved were listed (see Additional file
Metabolic pathways severely affected by knockout mutations are the biosynthesis of valine/leucine/isoleucine, the purine, fucose, glycerol and lipid metabolism, lower glycolysis as well as serine and glutathione production and aspartate semialdehyde biosynthesis. It is important to note that on the other hand, a huge landscape of central metabolism is not important for intracellular growth. This demonstrates not only the robustness of these central metabolic pathways, but also the difference in the phenotypes revealed by the comparison of growth in full medium with the intracellular replication. The overview from EPA indicates that the glycerol metabolism is most critical for intracellular survival. Further genes important for intracellular replication of
The strains EGDΔlmo2734, EGDΔlmo1085 and EGDΔlmo618 also showed a minor reduction of bacterial counts, which was more pronounced in the spleen (Figure
Recently, two independent studies have disclosed the expression profile of
Ami, Vip, and InlA are well known virulence factors that contribute to listerial adhesion to and invasion of eukaryotic cells, and there identification validates the screening procedure. Ami is an autolysin amidase involved in adhesion to epithelial cells [
Several of the genes that play a role intracellular replication as identified here are also known to be required for virulence of
A surprisingly high number of genes involved in various transport processes contribute to the intracellular replication of
The requirement of lmo2430 involved in ferrichrome transport, as well as of the iron uptake regulator Fur, points to a restriction of iron availability inside the cytosol, a finding that has also been reported for
Four genes involved in the synthesis of purines (
With respect to amino acid metabolism, the genes listed in Table
The identification of lmo0517 and lmo2831 that encode a phosphoglycerate mutase and a phosphoglucomutase, respectively, support the finding that the pentose phosphate cycle rather than glycolysis is the predominant pathway of sugar metabolism of
An important outcome of the systems biology approach described here is the fact that
Strains used in this study are listed in Table
Strains and plasmids used in this study
| name | characterization | reference |
|---|---|---|
| XL2-blue | Stratagene | |
| DH5α | [ |
|
| EGD | S. H. E. Kaufmann | |
| Pkp1 | [ |
|
| EGDΔlmo0135-137 | in-frame deletion mutant of a putative oligonucleotide transporter gene | This study |
| EGDΔ |
in-frame deletion mutant of lmo0190 involved in mevalonate biosynthesis | This study |
| EGDΔlmo0618 | in-frame deletion mutant of a protein kinase gene | This study |
| EGDΔlmo1031-1036 | In-frame deletion mutant of an operon responsible for glycerol metabolism | This study |
| EGDΔlmo1085 | in-frame deletion mutant of lmo1085 involved in teichoic synthesis | This study |
| EGDΔ |
in-frame deletion mutant of |
This study |
| EGDΔlmo1506 | in-frame deletion mutant of a putative transporter gene | This study |
| EGDΔ |
in-frame deletion mutant of the putative oligopeptide ABC transporter gene lmo2192 | This study |
| EGDΔlmo2734 | in-frame deletion mutant of lmo2734 encoding a putative sugar hydrolase | This study |
| EGDΔlmo2781 | in-frame deletion mutant of lmo2781 involved in cellobiose metabolism | This study |
| pLSV101 | Temperature-sensitive shuttle vector; EmR | [ |
| EGDΔ |
in-frame deletion mutant of |
This study |
DNA manipulations and isolation of chromosomal DNA were performed according to standard protocols [
A random mutant library of
In-frame deletions of ten genes or gene loci were performed in the parental strains Sv1/2a EGD, namely of lmo1031-1036, lmo0135-0137,
Caco-2 cells (2.5 × 105 per well) were seeded in a 24-well culture plate and cultivated 22 h until infection. Cells were washed twice with Mg2+-and Ca2+-containing phosphate-buffered saline (PBS/Mg2+Ca2+) and covered for 1 h with 500 μl RPMI 1640 containing 2.0 μl of a bacterial culture grown over night. The average multiplicity of infection (MOI) was calculated to range from 6 to 14. To test deletion mutants, strains were grown in 20 ml BHI to late log-phase (OD600~1.0); aliquots were supplemented with glycerol at a final concentration of 15% and frozen at -80°C. Prior to infection, glycerol stocks were thawed, and the bacteria were sedimented and washed twice with PBS. After resuspension in 1 ml RPMI 1640, the number of viable bacteria was determined as CFU. The average MOI used here was 8 to 11.
After an infection period of 1 h, the Caco-2 cells were washed twice with PBS/Mg2+Ca2+. Extracellular bacteria were removed by adding 0.5 ml RPMI 1640 with 50 μg/ml gentamicin for 1 h, and the medium was then replaced by RPMI 1640 with 10 μg/ml gentamicin. At appropriate time points of incubation (2 h and 8 h), the infected cells were washed with PBS/Mg2+Ca2+ and then lysed in 1 ml cold Triton X-100 (0.1%). Intracellular replication behaviour of the mutants and the wildtype was quantified by plating dilutions of the lysed cells on BHI agar plates that were incubated at 37°C and 43°C, respectively, for one day. If appropriate, the plates contained 5 μg/ml erythromycin. To examine adhesion properties of bacterial strains, the infection time was reduced to 35 min, and before lysis, cells were washed four times with PBS/Mg2+Ca2+. The capability of bacterial cells to invade Caco-2 cells was investigated as described above, but lysis of the epithelial cells was performed after 1 h, and a higher gentamicin concentration of 50 μg/ml was used. In all experiments, intact eukaryotic cell monolayers were observed prior to cell lysis.
Female BALB/c (H-2d) mice were purchased (Janvier, Le Geneste St. Isle, France), kept under conventional conditions, and used at 8-10 weeks of age. Animal experiments were approved according to German federal law (Baden-Württemberg, permission number G-3/06). Mice were infected intravenously via the tail vein with a sublethal dose of
The genome-scale metabolic network was reconstructed according to the latest annotation of
MOI: multiplicity of infection; IDM: insertion duplication mutagenesis
KS performed most experimental work with
Click here for file
Click here for file
Click here for file
Click here for file
Click here for file
Click here for file
The authors thank Samir Velagic for technical assistance. This work was supported by the Competence Center PathoGenoMik funded by the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF), Germany, and by the Priority Program SPP 1316 of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; Fu 375/5-1; Da 208/10-1;11-1).